Loading…
Enveric Biosciences, Inc. is projected to decline to $1.28 by 2027, a -6% move from its current price of $1.35. ENVB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.29 | $1.35 | $1.41 | -0.07% |
| Jul 14 | $1.26 | $1.35 | $1.44 | -0.14% |
| Jul 15 | $1.24 | $1.35 | $1.46 | -0.21% |
| Jul 16 | $1.23 | $1.35 | $1.48 | -0.28% |
| Jul 17 | $1.21 | $1.35 | $1.49 | -0.35% |
| Jul 18 | $1.20 | $1.34 | $1.51 | -0.42% |
| Jul 19 | $1.19 | $1.34 | $1.52 | -0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.19 | $1.34 | $1.52 | -0.49% |
| Week 2 | $1.13 | $1.34 | $1.59 | -0.97% |
| Week 3 | $1.08 | $1.33 | $1.64 | -1.45% |
| Week 4 | $1.04 | $1.32 | $1.69 | -1.93% |
| Week 5 | $1.00 | $1.32 | $1.73 | -2.40% |
| Week 6 | $0.9725 | $1.31 | $1.77 | -2.88% |
| Week 7 | $0.9449 | $1.30 | $1.80 | -3.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Enveric Biosciences, Inc. is a biotechnology company focused on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Enveric Biosciences, Inc. (ENVB) is a biotechnology company with a current price of $1.35 and a market capitalization of $5.44M. It is ranked 5249 by market capitalization.
The near-term price outlook is reflected in the 2026 forecast: min $1.28, avg $1.35, max $1.57 with ROI of 0% and a NEUTRAL sentiment.
Longer-term forecasts indicate upside beyond 2026, with 2030 avg $1.82 and ROI 35% (BULLISH), 2040 avg $2.40 and ROI 77.4% (BULLISH), and 2050 avg $3.52 and ROI 160.6% (BULLISH). The model also shows a max forecast of $8.09 by 2050. The 30-day technical picture remains volatile with a 30-day range and notable volatility.
A major floor 54.8% below — a decisive break under it would weaken the trend.
The nearest floor, 5.2% below — buyers have tended to step in here.
The nearest ceiling, 71.9% above — a clean break opens room to run.
A major ceiling 294.1% above — clearing it would confirm fresh momentum.
Key ENVB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENVB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.43 | Sell | $1.41 | Sell |
| MA 10 | $1.42 | Sell | $1.42 | Sell |
| MA 20 | $1.41 | Sell | $1.51 | Sell |
| MA 50 | $2.09 | Sell | $1.90 | Sell |
| MA 100 | $2.23 | Sell | $3.36 | Sell |
| MA 200 | $3.93 | Sell | $52.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.58 | Neutral |
| Stoch RSI (14) | 62.95 | Neutral |
| CCI (20) | -51.01 | Neutral |
| Williams %R (14) | -68.18 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 31.82 | Neutral |
| TRIX (15) | -1.75 | Sell |
| Awesome (5,34) | -0.24 | Sell |
| Ultimate (7,14,28) | 45.29 | Neutral |
| Momentum (10) | 0.07 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 1.41 | Sell |
| ADX (14) | 30.17 | Sell |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 40.
The 50-day simple moving average is $2.09 and the 200-day simple moving average is $3.93, with near-term support at $1.28 and resistance at $2.32.
The 30-day price range runs from $0.9962 to $1.83.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.28 | $1.35 | $1.57 | 0% | Neutral | |
| $0.9503 | $1.28 | $1.84 | -6% | Neutral | |
| $1.03 | $1.46 | $2.23 | +8% | Neutral | |
| $1.16 | $1.72 | $2.74 | +27% | Bullish | |
| $1.19 | $1.82 | $3.02 | +35% | Bullish | |
| $0.9687 | $1.54 | $2.63 | +14% | Neutral | |
| $0.8864 | $1.46 | $2.56 | +8% | Neutral | |
| $0.914 | $1.55 | $2.80 | +15% | Neutral | |
| $1.04 | $1.81 | $3.34 | +34% | Bullish | |
| $1.19 | $2.15 | $4.05 | +59% | Bullish | |
| $1.15 | $2.40 | $4.92 | +78% | Bullish | |
| $1.58 | $3.52 | $8.10 | +161% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.28 | $1.35 | $1.64 | +0.00% |
| August 2026 | $1.06 | $1.28 | $1.60 | -5.23% |
| September 2026 | $1.04 | $1.27 | $1.61 | -0.96% |
| October 2026 | $1.08 | $1.33 | $1.71 | +4.92% |
| November 2026 | $1.04 | $1.29 | $1.69 | -2.86% |
| December 2026 | $0.9492 | $1.19 | $1.57 | -8.04% |
Click any year to see its month-by-month ENVB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ENVB to range from $1.28 to $1.57 through 2026. The $1.35 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ENVB price prediction for 2027 points to an average of $1.28 (low $0.9503, high $1.84) — a potential decline of -6% on today's $1.35. A consolidation phase looks the most probable path here.
In 2028, ENVB is projected to trade between $1.03 and $2.23, averaging $1.46 — a potential gain of +8% from today's $1.35. That is up +14% on the projected 2027 average. Price action looks broadly range-bound.
Enveric Biosciences, Inc.'s 2029 outlook centres on $1.72, within a $1.16 to $2.74 range. That is up +18% on the projected 2028 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ENVB could reach as high as $3.02, with a base case around $1.82 and support toward $1.19 — roughly +35% from $1.35. Momentum favours further upside here.
Expect ENVB to range from $0.9687 to $2.63 through 2031. The $1.54 average target implies a +14% move from current prices. That is -15% versus the projected 2030 average. A consolidation phase looks the most probable path here.
The ENVB price prediction for 2032 points to an average of $1.46 (low $0.8864, high $2.56) — a potential gain of +8% on today's $1.35. Price action looks broadly range-bound.
In 2033, ENVB is projected to trade between $0.914 and $2.80, averaging $1.55 — a potential gain of +15% from today's $1.35. That is up +7% on the projected 2032 average. A consolidation phase looks the most probable path here.
Enveric Biosciences, Inc.'s 2034 outlook centres on $1.81, within a $1.04 to $3.34 range. That is up +17% on the projected 2033 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2035, ENVB could reach as high as $4.05, with a base case around $2.15 and support toward $1.19 — roughly +59% from $1.35. Buyers look set to stay in control over this stretch.
Expect ENVB to range from $1.15 to $4.92 through 2040. The $2.40 average target implies a +78% move from current prices. That is up +12% on the projected 2035 average. Momentum favours further upside here.
The ENVB price prediction for 2050 points to an average of $3.52 (low $1.58, high $8.10) — a potential gain of +161% on today's $1.35. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENVB today (≈ 740.740741 ENVB) could be worth
$2,608.6
+$1,608.6 (+161%) by 2050 · US Dollar
Based on the average projected ENVB price of $3.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENVBwould be worth at today's price.
$1,000 invested in ENVB on Jul 10, 2025 (≈ 61.728392 ENVB) would be worth
$83.33
-$916.67 (-91.7%) today · 0.08× · US Dollar
Based on a ENVB entry price of $16.2 vs. today's $1.35.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.45 | $931.03 | -6.9% |
| 1 month ago | $1.62 | $833.33 | -16.7% |
| 3 months ago | $1.96 | $687.72 | -31.2% |
| 6 months ago | $3.82 | $353.4 | -64.7% |
| 1 year ago | $16.2 | $83.33 | -91.7% |
| All time (5.0y) ago | $299,700 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENVB forecast.
Our base-case forecast reaches $2.70 around 2050.
Implied market cap at $2.70: $10.88M
Forecasts point to a gradually rising price and continued bullish sentiment in later years. In 2030, the average price is $1.82 with a 35% ROI and a BULLISH sentiment. In 2040, the average price rises to $2.40 with a 77.4% ROI and a BULLISH sentiment. In 2050, the average price reaches $3.52 with a 160.6% ROI and a BULLISH sentiment.
While these estimates imply meaningful upside over the long run, they also reflect substantial volatility, as indicated by the 90% annualized volatility. The current price is $1.35, and the forecasts show a wide potential range across years, including a max forecast of $8.09 by 2050.
Tap a question to reveal the answer.
Avg $1.82; min $1.19; max $3.02; ROI 35%; sentiment BULLISH.
Forecasts show bullish sentiment in 2030, 2040, and 2050 with ROIs of 35%, 77.4%, and 160.6% respectively, but there are years with negative or flat ROIs (e.g., 2027 at -5.4%) and overall volatility at 90%. These are estimates, not guarantees.
Yes. The max forecast listed is $8.09 in 2050.
The current price is $1.35.
Annualized volatility is 90%.
Enveric Biosciences, Inc. Community Discussion
0Share your Enveric Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.